Ondansetron Tablet, Orally Disintegrating
Product Images NDC 51655-008

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 51655-008). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 008 20)

Label for Ondansetron Orally Disintegrating Tablets USP 4 mg, containing 20 tablets. It is a prescription-only oral dosage form manufactured by Northwind Health Company, LLC, with NDC 51655-008. Storage instructions and safety warnings such as phenylketonurics information are included on the label.*

FDA Label Image

Logo (Logo)

FDA Label Image

Structure-base (Structure Base)

Chemical structure of ondansetron, showing the arrangement of rings and functional groups including an indole and a methyl-substituted imidazole connected via a carbonyl-containing ring.*

FDA Label Image

Structure-hcl (Structure HCl)

Chemical structure of Ondansetron hydrochloride dihydrate showing the molecular framework with fused rings, a ketone group, and a methyl-substituted imidazole ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.